T1	Participants 850 939	patients with myeloid leukemia undergoing allogeneic stem cell transplantation (allo-SCT)
T2	Participants 1417 1485	32 males and 19 females, with a median age of 45 years (range: 6-59)
T3	Participants 2805 2840	high-risk myeloid leukemia patients
